cysteine has been researched along with Dementia Praecox in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (21.67) | 18.7374 |
1990's | 13 (21.67) | 18.2507 |
2000's | 16 (26.67) | 29.6817 |
2010's | 14 (23.33) | 24.3611 |
2020's | 4 (6.67) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Chen, C; Cui, X; Li, Z; Liu, M; Pan, Y; Sun, J; Zhao, F | 1 |
Chen, YY; Chou, YH; Liu, MN; Yang, BH; Yang, KC | 1 |
Abohamza, E; Berry, T; Moustafa, AA | 1 |
Martínez-Banaclocha, M | 1 |
Chen, CC; Chong, MY; Hsu, ST; Huang, YC; Hung, CF; Lee, Y; Lin, CH; Lin, PY; Wang, LJ; Wu, CC | 1 |
Cressatti, M; Galindez, C; Liberman, A; Schipper, HM; Song, W; Tavitian, A | 1 |
Baik, HH; Chung, JH; Kim, JW; Kim, SK; Kim, YJ; Park, HJ; Yu, GI | 1 |
Aleksic, B; Furuichi, A; Kido, M; Nakamura, M; Nakamura, Y; Nishikawa, Y; Noguchi, K; Ozaki, N; Sasabayashi, D; Suzuki, M; Takahashi, T; Takayanagi, Y | 1 |
Araújo, D; Baker, GB; Bressan, RA; Chaves, C; Crippa, JA; Dursun, SM; Elkis, H; Ferrari, TB; Guimarães, FS; Hallak, JE; Machado-de-Sousa, JP; Maia-de-Oliveira, JP; Marque, CR; Santos, AC; Wichert-Ana, L; Zuardi, AW | 1 |
Bertolino, A; Blasi, G; Caforio, G; Callicott, JH; Di Giorgio, A; Gambi, F; Kolachana, B; Latorre, V; Nardini, M; Papazacharias, A; Popolizio, T; Rampino, A; Rizzo, M; Romano, R; Sambataro, F; Weinberger, DR | 1 |
Bald, E; Dietrich-Muszalska, A; Głowacki, R; Olas, B | 1 |
Hagino, H; Kawasaki, Y; Kobayashi, S; Kurachi, M; Maeno, N; Niu, L; Ozaki, N; Sasaoka, T; Seto, H; Suzuki, M; Takahashi, T; Tsuneki, H; Tsunoda, M; Zhou, SY | 1 |
Chen, HI; Hwang, R; Nakamura, J; Ohmori, O; Sakata, S; Shinkai, T; Utsunomiya, K; Yamada, K | 1 |
Eastwood, SL; Harrison, PJ; Hyde, TM; Kleinman, JE; Walker, M | 1 |
Hayashi, T; Horiguchi, J; Inagaki, T; Kawakami, K; Kitagaki, H; Miyaoka, T; Tsuchie, K; Wake, R; Yamamoto, Y | 1 |
Arinami, T; Itokawa, M; Toru, M | 1 |
Chen, YC; Chien, KL; Hong, CJ; Hsieh, CJ; Lai, MS | 1 |
Ichiba, M; Nakamura, M; Sano, A; Shimo, H; Tomiyasu, A; Ueno, S | 1 |
Chan, CH; Cheng, C; Chiu, HJ; Hwu, TM; Lan, TH; Liu, YR; Loh, el-W | 1 |
Alberni, J; Ariza, M; Delgado, L; Garolera, M; Pardo, BM; Pareto, D; Salamero, M; Valles, V | 1 |
Auquier, P; Boyer, L; Faget, C; Guedj, E; Lançon, C; Mundler, O; Padovani, R; Richieri, R; Vaillant, F | 1 |
CHANG, LT; CHI, M | 1 |
Ergül, E; Güzelhan, Y; Kara, I; Kaya, G; Sazci, A | 1 |
Chang, CY; Chen, H; Chen, HM; Chen, YE; Hong, CJ; Lee, SM; Liao, DL; Tsai, SJ | 1 |
Charney, DS; Erdos, J; Gelernter, J; Kennedy, JL; Klempan, TA; Kranzler, HR; Lappalainen, J; Luo, X; Rosenheck, RA; van Kammen, DP | 1 |
Bai, YM; Chen, JY; Lai, IC; Liao, DL; Lin, CC; Lin, MW; Liou, YJ; Wang, YC; Yu, SC | 1 |
Basile, VS; Ertugrul, A; Jayathilake, K; Kennedy, JL; Masellis, M; Meltzer, HY | 1 |
Grmek, M; Kocmur, M; Milcinski, M; Novak, B | 1 |
Glatt, SJ; Jönsson, EG | 1 |
Boronow, J; Dickerson, F; Origoni, A; Stallings, C; Yolken, R | 1 |
Burdick, KE; DeRosse, P; Goldman, D; Hodgkinson, CA; Kane, JM; Lencz, T; Malhotra, AK | 1 |
Faraone, SV; Glatt, SJ; Hwu, HG; Kanazawa, T; Lasky-Su, JA; Tsuang, MT | 1 |
Bueno, JR; Ginther, R; Himwich, HE; Spaide, J; Tanimukai, H | 2 |
Bodeau-Péan, S; Campion, D; d'Amato, T; Dollfus, S; Jay, M; Laurent, C; Martinez, M; Petit, M; Samolyk, D; Thibault, F | 1 |
Arinami, T; Futamura, N; Hamaguchi, H; Itokawa, M; Toru, M | 1 |
Dai, XY; Fukuda, R; Hattori, M; Kazamatsuri, H; Nanko, S | 2 |
Asherson, P; McGuffin, M; Owen, M; Roberts, E; Williams, N | 1 |
Arranz, M; Ball, D; Collier, D; Gill, M; Kerwin, R; Shaikh, S | 1 |
Fukushima, N; Igarashi, S; Ihda, S; Kameda, K; Onodera, O; Takahashi, M; Tanaka, H; Tanaka, T; Tsuji, S | 1 |
Badri, F; Bean, G; Howard, A; Hudson, CJ; Joffe, RT; Kennedy, JL; Lieberman, J; Macciardi, FM; Meltzer, HY; Sasaki, T; Verga, M | 1 |
Chen, CH; Chien, SH; Hwu, HG | 1 |
Bradley, R; Cai, X; Crawford, F; Dajani, N; Hoyne, J; Mullan, M; Osborne, A; Poston, D; Solomon, R; Walsh, S; Zaglul, J | 1 |
Breier, A; Buchanan, RW; Clifton, A; Goldman, D; Malhotra, AK; Ozaki, N; Pickar, D; Rooney, W | 1 |
Bönisch, H; Brüss, M; Bühlen, M; Göthert, M; Nöthen, MM; Propping, P | 1 |
An, SK; Jon, DI; Lee, JD; Min, SK | 1 |
Kurachi, M; Matsui, M; Nohara, S; Saitoh, O; Seto, H; Suzuki, M; Yamashita, I | 2 |
Lattuada, E; Lilli, R; Lorenzi, C; Serretti, A; Smeraldi, E | 1 |
Beaton, JM | 1 |
Bueno, J; Ginther, R; Himwich, HE; Spaide, J; Tanimukai, H | 1 |
Fujimori, M; Haskovec, L; Heller, B; Himwich, HE; Narasimhachari, N; Spaide, J; Tabushi, K | 2 |
Himwich, HE; Narasimhachari, N; Plaut, J | 1 |
Caridroit, M; Duc-Aublet, F; Fontan, M; Miens, C; Testegute, T | 1 |
Davis, JM; Himwich, HE; Spaide, JK | 2 |
Himwich, HE; Narasimhachari, N | 1 |
Bueno, JR; Himwich, HE; Spaide, J; Tanimukai, H | 1 |
5 review(s) available for cysteine and Dementia Praecox
Article | Year |
---|---|
Treatment-resistant schizophrenia: focus on the transsulfuration pathway.
Topics: Cystathionine beta-Synthase; Cysteine; Drug Resistance; Glutathione; Humans; Hydrogen Sulfide; Schizophrenia | 2020 |
N-acetyl-cysteine in Schizophrenia: Potential Role on the Sensitive Cysteine Proteome.
Topics: Acetylcysteine; Antioxidants; Cysteine; Glutathione; Humans; Oxidation-Reduction; Proteome; Schizophrenia | 2020 |
Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
Topics: Alleles; Animals; Cysteine; Dopamine; Drug Discovery; Humans; Mental Disorders; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia; Serine; Signal Transduction | 2010 |
The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.
Topics: Alleles; Amino Acid Substitution; Cysteine; Gene Frequency; Genotype; Humans; Polymorphism, Genetic; Receptors, Dopamine D2; Risk Factors; Schizophrenia | 2006 |
Methylation & schizophrenia.
Topics: Amines; Amino Acids; Animals; Behavior, Animal; Catecholamines; Cats; Cystathionine; Cysteine; Dihydroxyphenylalanine; Drug Tolerance; Hallucinogens; Homocysteine; Humans; Indoles; Methionine; Methylation; Mice; Schizophrenia; Serine; Taurine | 1975 |
2 trial(s) available for cysteine and Dementia Praecox
Article | Year |
---|---|
Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia.
Topics: Adult; Antipsychotic Agents; Brain; Cerebrovascular Circulation; Cysteine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Minocycline; Organ Size; Organotechnetium Compounds; Psychiatric Status Rating Scales; Radiopharmaceuticals; Schizophrenia; Signal Processing, Computer-Assisted; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Young Adult | 2015 |
Early effects of treatment on regional cerebral blood flow in first episode schizophrenia patients evaluated with 99Tc-ECD-SPECT.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain Mapping; Cerebrovascular Circulation; Cysteine; Frontal Lobe; Humans; Male; Middle Aged; Olanzapine; Organotechnetium Compounds; Psychiatric Status Rating Scales; Radiopharmaceuticals; Regional Blood Flow; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon | 2005 |
53 other study(ies) available for cysteine and Dementia Praecox
Article | Year |
---|---|
Simultaneous determination of serum homocysteine, cysteine, and methionine in patients with schizophrenia by liquid chromatography-tandem mass spectrometry.
Topics: Chromatography, Liquid; Cysteine; Homocysteine; Humans; Methionine; Schizophrenia; Tandem Mass Spectrometry | 2022 |
Interactions between dopamine transporter and N-methyl-d-aspartate receptor-related amino acids on cognitive impairments in schizophrenia.
Topics: Amino Acids; Arginine; Aspartic Acid; Cognitive Dysfunction; Corpus Striatum; Cysteine; Dopamine; Dopamine Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Glutamates; Humans; Methionine; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Tropanes | 2022 |
Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation.
Topics: Adult; Aged; Blood Glucose; Case-Control Studies; Cognition Disorders; Cross-Sectional Studies; Cysteine; Executive Function; Fasting; Female; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Verbal Learning | 2018 |
Cysteine-rich whey protein isolate (Immunocal®) ameliorates deficits in the GFAP.HMOX1 mouse model of schizophrenia.
Topics: Administration, Oral; Animals; Behavior, Animal; Cysteine; Dietary Supplements; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutathione; Heme Oxygenase-1; Humans; Male; Membrane Proteins; Mice; Mice, Transgenic; Oxidative Stress; Schizophrenia; Whey Proteins | 2017 |
A polymorphism (rs4773092, Cys816Cys) of IRS2 affects auditory hallucinations in schizophrenia patients.
Topics: Adult; Cysteine; Female; Gene Frequency; Genotype; Hallucinations; Humans; Insulin Receptor Substrate Proteins; Male; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia | 2013 |
The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain neurodevelopmental markers in schizophrenia and healthy subjects.
Topics: Adult; Analysis of Variance; Brain; Chi-Square Distribution; Cysteine; Female; Functional Laterality; Genotype; Humans; Magnetic Resonance Imaging; Male; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Schizophrenia; Serine; Young Adult | 2015 |
Association of the SerCys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding.
Topics: Adult; Alleles; Amino Acid Sequence; Amino Acid Substitution; Cysteine; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory; Memory Disorders; Nerve Tissue Proteins; Neural Pathways; Polymorphism, Genetic; Prefrontal Cortex; Schizophrenia; Serine; Young Adult | 2008 |
Oxidative/nitrative modifications of plasma proteins and thiols from patients with schizophrenia.
Topics: Adult; Biomarkers; Blood Proteins; Chromatography, High Pressure Liquid; Cysteine; Dipeptides; Enzyme-Linked Immunosorbent Assay; Female; Glutathione; Homocysteine; Humans; Male; Oxidative Stress; Schizophrenia; Tyrosine | 2009 |
The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia.
Topics: Adult; Brain; Cognition Disorders; Cysteine; Female; Frontal Lobe; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Homozygote; Humans; Magnetic Resonance Imaging; Male; Nerve Tissue Proteins; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia; Schizophrenic Psychology; Serine | 2009 |
A functional polymorphism (Ser326Cys) of the human 8-oxoguanine DNA glycosylase (hOGG1) gene and schizophrenia.
Topics: Adult; Cysteine; DNA Glycosylases; Female; Gene Frequency; Genome-Wide Association Study; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia; Serine | 2010 |
The DISC1 Ser704Cys substitution affects centrosomal localization of its binding partner PCM1 in glia in human brain.
Topics: Adult; Amino Acid Substitution; Autoantigens; Brain; Cell Cycle Proteins; Centrosome; Cysteine; Female; Humans; Male; Middle Aged; Nerve Tissue Proteins; Neuroglia; Schizophrenia; Serine | 2010 |
Characteristic brain hypoperfusion by 99mTc-ECD single photon emission computed tomography (SPECT) in patients with the first-episode schizophrenia.
Topics: Adult; Brain; Case-Control Studies; Cerebrovascular Circulation; Cysteine; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Schizophrenia; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2010 |
Genetic variability in serotonin receptor and transporter genes may influence risk for tardive dyskinesia in chronic schizophrenia.
Topics: Antipsychotic Agents; Cysteine; Disease Susceptibility; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Movement Disorders; Polymorphism, Single Nucleotide; Receptors, Serotonin, 5-HT3; Risk Factors; Schizophrenia; Serotonin Plasma Membrane Transport Proteins; Taiwan; Threonine | 2011 |
Comprehensive analysis of the genes responsible for neuroacanthocytosis in mood disorder and schizophrenia.
Topics: Amino Acid Transport Systems, Neutral; Cysteine; DNA Copy Number Variations; DNA Mutational Analysis; Humans; Japan; Mood Disorders; Neuroacanthocytosis; Schizophrenia; Tyrosine; Vesicular Transport Proteins | 2011 |
Association of the ADRA1A gene and the severity of metabolic abnormalities in patients with schizophrenia.
Topics: Adult; Arginine; Cysteine; Female; Gene Frequency; Genetic Association Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Adrenergic, alpha-1; Risk Factors; Schizophrenia; Severity of Illness Index | 2012 |
Improvement of cognitive flexibility and cingulate blood flow correlates after atypical antipsychotic treatment in drug-naive patients with first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Organotechnetium Compounds; Psychiatric Status Rating Scales; Schizophrenia; Statistics as Topic; Tomography, Emission-Computed, Single-Photon; Young Adult | 2011 |
Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia.
Topics: Adult; Brain Mapping; Cysteine; Female; Functional Laterality; Humans; Male; Organotechnetium Compounds; Psychiatric Status Rating Scales; Quality of Life; Radiopharmaceuticals; Regional Blood Flow; Schizophrenia; Schizophrenic Psychology; Surveys and Questionnaires; Temporal Lobe; Tomography, Emission-Computed, Single-Photon; Young Adult | 2012 |
AN INVESTIGATION INTO THE PROTEIN METABOLISM OF SCHIZOPHRENICS AND ITS CLINICAL SIGNIFICANCE.
Topics: China; Chromatography; Cysteine; Cystine; Indoles; Kidney; Proteins; Renal Aminoacidurias; Schizophrenia; Tryptophan | 1963 |
Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia.
Topics: Alanine; Alleles; Chi-Square Distribution; Cysteine; DNA Mutational Analysis; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Lymphocytes; Methylenetetrahydrofolate Reductase (NADPH2); Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Schizophrenia; Threonine | 2003 |
Association of muscarinic m1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients.
Topics: Adolescent; Adult; Aged; Alanine; Case-Control Studies; Cognition; Cysteine; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Polymerase Chain Reaction; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptor, Muscarinic M1; Receptors, Muscarinic; Schizophrenia; Schizophrenic Psychology | 2003 |
NOTCH4 gene haplotype is associated with schizophrenia in African Americans.
Topics: Alleles; Black or African American; Chi-Square Distribution; Cysteine; Diagnostic and Statistical Manual of Mental Disorders; Female; Gene Frequency; Genotype; Glycine; Haplotypes; Humans; Linkage Disequilibrium; Male; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins; Receptor, Notch4; Receptors, Cell Surface; Receptors, Notch; Schizophrenia; Threonine | 2004 |
Cytochrome P-450 2D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardive dyskinesia in Chinese schizophrenic patients.
Topics: Adult; Alleles; Amino Acid Substitution; Antipsychotic Agents; Asian People; Cysteine; Cytochrome P-450 CYP2D6; Dyskinesia, Drug-Induced; Female; Genotype; Humans; Logistic Models; Male; Middle Aged; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Sex Factors; Statistics, Nonparametric; Threonine | 2004 |
No association of the T102C polymorphism of the serotonin 2A receptor gene (HTR2A) with suicidality in schizophrenia.
Topics: Adult; Analysis of Variance; Cysteine; Female; Gene Frequency; Genotype; Humans; Male; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Schizophrenia; Suicide; Threonine | 2004 |
The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia.
Topics: Adult; Antibodies, Viral; Arginine; Bipolar Disorder; Cognition Disorders; Cysteine; Female; Genetic Predisposition to Disease; Genotype; Herpesvirus 1, Human; Humans; Intelligence; Lymphotoxin-alpha; Male; Middle Aged; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia | 2007 |
Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia.
Topics: Cysteine; Delusions; Genetic Carrier Screening; Genetic Predisposition to Disease; Genotype; Hallucinations; Haplotypes; Homozygote; Humans; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Serine | 2007 |
Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan.
Topics: Asian People; Case-Control Studies; Cysteine; Family Health; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Male; Polymorphism, Single Nucleotide; Receptors, Dopamine D2; Risk; Schizophrenia; Serine; Taiwan | 2009 |
Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients.
Topics: Adult; Chromatography, Gas; Chromatography, Paper; Chromatography, Thin Layer; Cysteine; Hallucinogens; Humans; Male; Middle Aged; Schizophrenia; Serotonin; Tranylcypromine; Tryptamines | 1967 |
No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia.
Topics: Alleles; Cysteine; Female; France; Gene Frequency; Humans; Male; Pedigree; Point Mutation; Receptors, Dopamine D2; Schizophrenia; Serine; White People | 1994 |
A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).
Topics: Alleles; Base Sequence; Brain; Chromosome Mapping; Chromosomes, Human, Pair 11; Cysteine; DNA; DNA Primers; Exons; Genes, Regulator; Genetic Carrier Screening; Homozygote; Humans; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Receptors, Dopamine D2; Schizophrenia; Serine | 1993 |
DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Topics: Cysteine; Female; Humans; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia; Serine | 1994 |
DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Topics: Cysteine; Humans; Japan; Receptors, Dopamine D2; Schizophrenia; Serine | 1994 |
DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Topics: Cysteine; Humans; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia; Serine | 1994 |
Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia.
Topics: Alleles; Base Sequence; Cysteine; DNA; Female; Genotype; Humans; Japan; Male; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Receptors, Dopamine D2; Schizophrenia; Serine | 1994 |
Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cysteine; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Point Mutation; Receptors, Dopamine D2; Schizophrenia | 1996 |
No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
Topics: Adult; Age of Onset; Amino Acid Sequence; Bipolar Disorder; Cysteine; Delusions; Female; Genetic Variation; Humans; Male; Middle Aged; Psychotic Disorders; Receptors, Dopamine D2; Reference Values; Schizophrenia; Serine; White People | 1996 |
No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients.
Topics: Adult; Amino Acid Sequence; China; Cysteine; Female; Genetic Variation; Humans; Male; Nuclear Family; Polymerase Chain Reaction; Receptors, Dopamine D2; Risk Assessment; Risk Factors; Schizophrenia | 1996 |
Dopamine DRD2/Cys311 is not associated with chronic schizophrenia.
Topics: Asian People; Base Sequence; Codon; Cysteine; DNA Primers; Gene Frequency; Genetic Variation; Humans; Japan; Point Mutation; Polymerase Chain Reaction; Receptors, Dopamine D2; Schizophrenia; Serine; United States; White People | 1996 |
Clozapine response and the 5HT2C Cys23Ser polymorphism.
Topics: Alleles; Antipsychotic Agents; Base Sequence; Clozapine; Cysteine; DNA Primers; Female; Genetic Carrier Screening; Homozygote; Humans; Male; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Predictive Value of Tests; Psychotic Disorders; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Schizophrenia; Serine | 1996 |
Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor.
Topics: Animals; Base Sequence; Bipolar Disorder; COS Cells; Cysteine; DNA Primers; DNA, Complementary; Humans; Ligands; Protein Binding; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Schizophrenia | 1999 |
Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study.
Topics: Adult; Brain; Cerebrovascular Circulation; Cysteine; Dominance, Cerebral; Female; Frontal Lobe; Humans; Male; Organotechnetium Compounds; Psychiatric Status Rating Scales; Radiopharmaceuticals; Schizophrenia; Schizophrenic Psychology; Temporal Lobe; Thalamus; Tomography, Emission-Computed, Single-Photon | 1999 |
Neural correlates of memory organization deficits in schizophrenia. A single photon emission computed tomography study with 99mTc-ethyl-cysteinate dimer during a verbal learning task.
Topics: Adult; Cysteine; Frontal Lobe; Functional Laterality; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory Disorders; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Schizophrenia; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Verbal Learning | 2000 |
Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses.
Topics: Adult; Amino Acid Substitution; Bipolar Disorder; Cysteine; Depressive Disorder; Female; Genetic Variation; Humans; Male; Middle Aged; Psychotic Disorders; Receptors, Dopamine D2; Reference Values; Schizophrenia; Schizophrenia, Paranoid; Serine | 2000 |
[Neural correlates of memory organization deficits in schizophrenia--a single photon emission computed tomography study with 99mTc-ECD during a verbal learning task].
Topics: Adult; Brain; Cerebrovascular Circulation; Cysteine; Humans; Male; Memory; Memory Disorders; Organotechnetium Compounds; Radiopharmaceuticals; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon; Verbal Learning | 2001 |
Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
Topics: Adult; Catatonia; Creatine; Cysteine; Humans; Indoleacetic Acids; Male; Middle Aged; Niacinamide; Paranoid Disorders; Schizophrenia; Tranylcypromine; Tryptamines; Tryptophan | 1967 |
Urinary studies of schizophrenics and controls.
Topics: Adult; Behavior; Blood Pressure; Chromatography, Gas; Chromatography, Thin Layer; Creatinine; Cysteine; Hallucinogens; Heart Rate; Humans; Indoleacetic Acids; Male; Middle Aged; MMPI; Psychiatric Status Rating Scales; Respiration; Schizophrenia; Thinking; Tranylcypromine; Tryptamines | 1971 |
3:4-Dimethoxyphenylethylamine, a normal or abnormal metabolite?
Topics: Chromatography, Thin Layer; Cysteine; Humans; Monoamine Oxidase Inhibitors; Phenethylamines; Schizophrenia; Ultraviolet Rays | 1972 |
[Biochemical study of a schizophreniac].
Topics: Adult; Cysteine; Humans; Male; Methylation; Monoamine Oxidase Inhibitors; Phenylalanine; Schizophrenia; Transferases; Tryptophan | 1973 |
Effects of tranylcypromine and L-cysteine on plasma amino acids in controls and schizophrenic patients.
Topics: Adult; Amino Acids; Behavior; Cysteine; Drug Synergism; Humans; Male; Middle Aged; Paranoid Disorders; Schizophrenia; Schizophrenia, Disorganized; Tranylcypromine | 1972 |
The determination of bufotenin in urine of schizophrenic patients and normal controls.
Topics: Adult; Aged; Chromatography, Thin Layer; Cysteine; Hallucinogens; Humans; Methods; Middle Aged; Monoamine Oxidase Inhibitors; Schizophrenia | 1972 |
Plasma amino acids in schizophrenic patients with methionine or cysteine loading and a monoamine oxidase inhibitor.
Topics: Adult; Amino Acids; Autoanalysis; Chronic Disease; Cysteine; Drug Synergism; Humans; Male; Methionine; Middle Aged; Schizophrenia; Schizophrenic Psychology; Stimulation, Chemical; Time Factors; Tranylcypromine | 1971 |
Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
Topics: 5-Hydroxytryptophan; Adult; Chromatography, Gas; Chromatography, Paper; Chromatography, Thin Layer; Cysteine; Hallucinogens; Humans; Male; Methionine; Middle Aged; Schizophrenia; Serotonin; Tranylcypromine; Tryptamines; Tryptophan | 1970 |
Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
Topics: Adult; Amines; Behavior; Chromatography, Gas; Chromatography, Ion Exchange; Chromatography, Thin Layer; Creatinine; Cysteine; Diet; Hallucinogens; Humans; Indoleacetic Acids; Male; Methionine; Middle Aged; Schizophrenia; Spectrum Analysis; Tranylcypromine; Tryptamines; Tryptophan | 1970 |
Behavioral and biochemical alterations in schizophrenic patients.
Topics: Adult; Behavior; Creatinine; Cysteine; Hallucinogens; Humans; Male; Methionine; Middle Aged; Monoamine Oxidase Inhibitors; Schizophrenia; Tryptamines | 1968 |